Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / May / Seeing ROP Clearly
Retina Technology Pediatric

Seeing ROP Clearly

How AI and XR simulations are transforming training for retinopathy of prematurity

By Richard Vincent 5/7/2026 4 min read

Share

  • Full Article
  • Summary
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions

Clinical Report: Seeing ROP Clearly

Overview

This report discusses the challenges and advancements in training for retinopathy of prematurity (ROP) treatment, emphasizing the role of XR simulation and AI in enhancing surgical education. These technologies aim to address the shortage of specialists and improve outcomes for premature infants at risk of blindness.

Background

Retinopathy of prematurity (ROP) is a significant cause of childhood blindness, affecting thousands of premature infants annually. The complexity of diagnosing and treating ROP requires specialized skills that are difficult to acquire due to limited case availability and steep learning curves. Innovative training methods, such as XR simulation and AI, are emerging to bridge the gap in specialist training and improve patient outcomes.

Data Highlights

No numerical data available in the source material.

Key Findings

  • XR simulation allows trainees to practice critical skills without risking patient safety.
  • AI-driven platforms provide objective performance metrics, enhancing competency assessments.
  • Immersive training can accelerate surgical learning and reduce operating room training time.
  • Standardized training through XR can be implemented globally, addressing disparities in ROP care.
  • Training in XR environments can help prepare clinicians for the unique challenges of treating premature infants.

Clinical Implications

Healthcare professionals should consider integrating XR simulation and AI into their training programs to enhance the skills of ophthalmology trainees. These technologies can provide a scalable solution to the shortage of specialists and improve the quality of care for infants at risk of ROP.

Conclusion

The integration of XR and AI in ROP training represents a significant advancement in ophthalmologic education, with the potential to improve surgical outcomes and address the global burden of preventable childhood blindness.

References

  1. Darius M. Moshfeghi, Antonio Capone, Jr., Retinal Physician, 2008 -- Do Cost Concerns Limit Screening for Retinopathy of Prematurity?
  2. Retinal Physician, 2025 -- Incorporating AI Into Global ROP Care
  3. Retinal Physician, 2026 -- Prevent Blindness Declares Third Annual ROP Awareness Week
  4. Retinal Physician, 2018 -- New Tool Improves Screening for ROP
  5. Smith-Kettlewell Eye Research -- Screening Examination of Premature Infants for Retinopathy of Prematurity.
  6. JAMA Network -- Revised Indications for the Treatment of Retinopathy of Prematurity: Results of the Early Treatment for Retinopathy of Prematurity Randomized Trial
  7. Screening Examination of Premature Infants for Retinopathy of Prematurity. | Smith-Kettlewell Eye Research
  8. Revised Indications for the Treatment of Retinopathy of Prematurity: Results of the Early Treatment for Retinopathy of Prematurity Randomized Trial | Neonatology | JAMA Ophthalmology | JAMA Network

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

View Full Profile Follow
Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: